Meeting NewsVideo

VIDEO: How did I drop that nucleus?

January 18, 2020
NEW YORK — During a presentation at OSN New York 2019, John A. Hovanesian, MD, FACS, discusses a problematic case study.
Meeting News

Adverum reports significant progress with intravitreal gene therapy program

January 17, 2020
Adverum Biotechnologies has made significant progress in its lead clinical program for intravitreal gene therapy for retinal diseases, Leone

Phase 3 trial to investigate Port Delivery System in DME

January 17, 2020
Genentech and Roche initiated a phase 3 clinical trial to investigate the Port Delivery System with ranibizumab to treat patients with diabetic…
Meeting NewsVideo

VIDEO: Presbyopic IOL challenge

January 17, 2020
NEW YORK — During a presentation at OSN New York 2019, William F. Wiley, MD, reviews his use of the Kamra inlay (CorneaGen) to address a…
Blog

BLOG: Ocular biomarkers for Alzheimer’s disease

January 17, 2020
by Leonard V. Messner OD, FAAO Alzheimer’s disease is a global disease of central nervous system dysfunction. Although public discourse about…

Kala completes enrollment in STRIDE 3 trial

January 17, 2020
Kala Pharmaceuticals has completed enrollment in the STRIDE 3 trial for KPI-121 0.25%, a treatment for temporary dry eye relief, according to a press…

Q&A: Vision training to improve athletic performance

January 16, 2020
Athletes are continually looking for ways to improve their performance and gain an advantage in training to give them a leg up on their competition. …
Meeting News

Glaukos leverages acquisitions to enter new ophthalmology spaces

January 16, 2020
With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more…
In the JournalsPerspective

Study finds prostaglandins change ocular surface

January 16, 2020
The ocular surface was found to change in patients treated with prostaglandin analogues, according to a literature review published in the Journal of

First US patient implanted with wireless retinal device

January 16, 2020
A surgeon at the UPMC Eye Center has implanted the first patient in the United States with a wireless retinal device to restore partial sight to…
Residency to Retirement Resource Center

Where does your financial advisor’s duty lie?

January 16, 2020
In the first article of this three-part series on investing we discussed the potential pitfalls of going it alone; current evidence suggests that…
In the Journals

Ocular changes differ in ground-based analogue of weightlessness

January 15, 2020
Subjects who underwent a ground-based analogue of weightlessness experienced greater peripapillary total retinal thickness but less choroidal…

FDA, NIDA call for marijuana legislation to advance public health

January 15, 2020
Leaders from the FDA and the National Institute on Drug Abuse said during a recent House Committee on Energy and Commerce hearing that there is a…
Meeting News

Oyster Point’s dry eye nasal spray meets phase 2 endpoints

January 15, 2020
Oyster Point Pharma’s nasal spray treatment for dry eye disease has met its primary endpoints in the phase 2 MYSTIC trial, CEO and President…

CustomFlex artificial iris receives transitional pass-through payment status

January 15, 2020
The CustomFlex artificial iris was granted transitional pass-through payment status from CMS, effective Jan. 1, 2020. The artificial iris from VEO…
In the JournalsPerspective

OCTA of choroidal microvasculature may facilitate glaucoma diagnoses

January 15, 2020
The use of OCT angiography in examining choroidal microvasculature may expedite glaucoma diagnoses in highly myopic eyes, according to findings…

LumiThera completes Series C funding tranche

January 15, 2020
LumiThera has completed the second tranche of its Series C funding round to support clinical testing and commercialization of the Valeda light…
Meeting News

Santen plans entry in US glaucoma market

January 14, 2020
Santen plans to break into the U.S. glaucoma market in 2020 with the introduction of the DE-128 microshunt, according to a speaker at the 38th annual…
In the JournalsPerspective

Smartphone tonometer provides reliable preliminary IOP

January 14, 2020
Calculating preliminary IOP using a smartphone-based tonometer yielded similar results compared with other tonometers, according to findings…

Iveric plans design of new Zimura trial

January 14, 2020
Iveric bio announced the design of a second pivotal trial for Zimura, a complement C5 inhibitor in development for the treatment of geographic…